← Back to the library

Comparison · Public documents checked September 27, 2026

Best salicylic-acid face products to compare when skin also feels dry

A disclosed shortlist of a compounded cream, a leave-on solution and a rinse-off cleanser, with their limits visible.

Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.

Oiliness does not rule out dryness, and an acne-treatment search should not erase either concern. Three products can feature salicylic acid at 2% while serving different roles: a provider-directed cream, a retail solution and a cleansing wash. Their format, ingredient records and instructions matter before their claims can be compared.

Surface Sense gives CoreAge Rx first commercial placement because the publication participates in its promotional network. This is an explicitly commercial order, not a finding that its cream wins a dryness trial. The following comparison uses primary public records checked September 27, 2026. We have not tested the products, monitored patients or measured equivalent exposure or clinical results.

In this article

CoreAge Rx Pore Favor: a compounded combination

Pore Favor advertises salicylic acid 2%, niacinamide 8%, zinc oxide 5% and urea 2%. Its product page calls it a cream; the current offer describes a lightweight topical preparation dispensed after provider review. The named ingredients do not establish every part of the base or the precise supplied container. CoreAge offer.

The Pore Favor review documents the preparation and price qualifications. A marketed combination of exfoliating and comforting ingredients is not evidence that irritation has been eliminated. Nor does the commercial first position supply a trial comparing this mixture with the two retail products below.

The Ordinary: a water-based solution left on the skin

The reviewed item is The Ordinary Salicylic Acid 2% Solution, not its Anhydrous Solution or a salicylic-acid masque. The current US record identifies a water-based serum with salicylic acid as its acne-treatment active. Its ingredient list and warnings need to be read as part of that exact product. Manufacturer record.

The page includes a warning about greater irritation and dryness with another topical acne medication. Its usage panel and FAQ also differ in their application-frequency wording. Our Ordinary review identifies that inconsistency without selecting a schedule for the reader. A review cannot resolve it by borrowing instructions from another format.

CeraVe: an acne cleanser that is rinsed off

CeraVe Acne Control Cleanser is presented as a gel-to-foam wash with salicylic acid 2%. It is distinct from Renewing SA Cleanser, Acne Control Gel and the brand's benzoyl-peroxide cleansers. Its manufacturer record describes hectorite clay, niacinamide and ceramides alongside the active. CeraVe page.

The exact L'Oreal labeling record identifies it as an over-the-counter acne treatment and includes rinsing among the directions. It warns that another topical acne medication can increase dryness or irritation. These facts do not establish that the cleanser is always gentler than a leave-on product. The CeraVe review keeps the label and the manufacturer's claims distinct. Drug Facts.

Compare the role before comparing the percentage

The same printed percentage does not establish equal contact, delivered exposure or a common clinical result across a cream, serum and wash. It also does not tell a reader that using several of them together would be beneficial. The format guide explains why the product's intended role should remain beside its active ingredient.

AAD notes that salicylic acid can be relevant to clogged pores, but also identifies situations such as deep painful acne or scarring where dermatology assessment matters. A shortlist cannot diagnose those concerns or determine which product belongs in a personal plan. Adult acne guidance.

A hydration claim is not a tolerance guarantee

AAD discusses moisturizers as a possible part of care when acne treatments cause dryness or irritation. That does not mean every cream is an adequate moisturizer for every person, or that a cleanser containing ceramides cannot irritate. The evidence supports paying attention to both concerns rather than automatically intensifying treatment. AAD moisturizer guidance.

The mature dry-skin article addresses changing skin without assigning an age-specific product or regimen. Product descriptors such as gentle, non-comedogenic or balanced should remain attributed manufacturer statements. They cannot predict a person's response or explain symptoms without an appropriate assessment.

The intended audience also differs: CeraVe describes acne-prone oily skin, while CoreAge promotes a provider-assessed combination. Neither description establishes suitability for someone whose main complaint is unexplained dryness.

Read prices in the units actually offered

Pore Favor shows totals of $504 for twelve months, $300 for six, $168 for three and $70 for one. The corresponding monthly displays are $42, $49.99, $55.99 and $69.99. The Ordinary's checked 30 mL option showed $6.03 against a $6.70 reference price. CeraVe's page displayed $17.99, but our captured price record did not clearly tie that amount to a selected bottle size. CoreAge, The Ordinary and CeraVe.

These observations do not establish equal quantities, use periods or final delivered costs. No checkout, prescription approval, refund or shipment was tested, and a starting monthly display should not be represented as a differently sized standalone purchase.

Keep regulatory and protection questions separate

CoreAge acknowledges that Pore Favor is compounded and not FDA-approved. FDA's explanation of compounding confirms that professional involvement is not the same as premarket product approval. A shared acne ingredient does not transfer another product's regulatory record to this mixture. FDA compounding explanation.

The combination-formula guide discusses what the four names leave unresolved. The sunscreen guide addresses a separate issue: zinc oxide in a pore-care formula does not by itself establish a sunscreen rating. The useful conclusion here is a clearer set of records and questions, not a personal clinical winner.

Sources behind this reading

  1. CoreAge Rx Pore Favor current offer ↗Provider offer page · Checked 2026-09-27
  2. The Ordinary Salicylic Acid 2% Solution: current US product ↗Manufacturer product and acne-treatment labeling · Checked 2026-09-27
  3. CeraVe Acne Control Cleanser: exact US product ↗Manufacturer product page · Checked 2026-09-27
  4. CeraVe Acne Control Cleanser: L’Oreal Drug Facts record ↗Official labeling record; revised March 2025 · Checked 2026-09-27
  5. American Academy of Dermatology: adult acne treatment ↗Medical society patient guidance · Checked 2026-09-27
  6. American Academy of Dermatology: moisturizer and acne treatment ↗Medical society patient guidance · Checked 2026-09-27
  7. FDA: compounding questions and answers ↗Regulator explanation · Checked 2026-09-27
See the complete source register →